del savio, maria chiara
 Distribuzione geografica
Continente #
NA - Nord America 713
EU - Europa 253
AS - Asia 127
AF - Africa 4
OC - Oceania 3
SA - Sud America 1
Totale 1.101
Nazione #
US - Stati Uniti d'America 712
IT - Italia 81
SE - Svezia 63
CN - Cina 47
HK - Hong Kong 44
DE - Germania 40
GB - Regno Unito 40
SG - Singapore 18
BG - Bulgaria 12
MY - Malesia 11
FI - Finlandia 7
ID - Indonesia 5
RU - Federazione Russa 4
AU - Australia 3
IN - India 2
SN - Senegal 2
TN - Tunisia 2
BE - Belgio 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
FR - Francia 1
IE - Irlanda 1
RO - Romania 1
UA - Ucraina 1
Totale 1.101
Città #
Fairfield 137
Chandler 102
Ashburn 70
Nyköping 53
Hong Kong 44
Woodbridge 39
Seattle 33
Cambridge 31
Wilmington 30
Ann Arbor 26
New York 25
Houston 24
Southend 24
Modena 20
San Diego 18
Princeton 17
Singapore 16
Beijing 15
Bremen 14
Sofia 12
Dearborn 8
Shanghai 7
Helsinki 6
Bologna 5
Jakarta 5
London 5
Milan 5
Zola Predosa 5
Eugene 4
Norwalk 4
Redwood City 4
Los Angeles 3
Melbourne 3
Parma 3
Berlin 2
Catanzaro 2
Dakar 2
Florence 2
Pune 2
San Jose 2
Soliera 2
Tunis 2
Venice 2
Vercelli 2
Vicenza 2
Asti 1
Baranzate 1
Barletta 1
Birmingham 1
Borås 1
Chiswick 1
Côré 1
Dublin 1
Esslingen am Neckar 1
Frattamaggiore 1
Gunzenhausen 1
Hounslow 1
Kilburn 1
Lappeenranta 1
Lianyun 1
Nanjing 1
Naples 1
Ningbo 1
Paris 1
Pavullo nel Frignano 1
Piacenza 1
Prato 1
Prescot 1
Redmond 1
Rimini 1
Rome 1
San Mateo 1
Scandiano 1
Serdiana 1
Shenzhen 1
Southwark 1
Spoleto 1
Totale 871
Nome #
Combined hormonal contraceptives in BRCA gene mutation carriers: why not? 156
Hereditary ovarian cancers: State of the art 124
BRCA mutation carriers' perceptions on postmenopausal hormone therapy: An Italian study 87
Surface roughness of different contraceptive vaginal rings: evaluation by scanning electron microscope (SEM) 85
Attitudes of women towards products containing hormones (hormonal contraceptives or hormone therapy): what changes from pre to postmenopause? 84
The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: A prospective cohort, other biomarker controlled, study 80
Estetrol (E4): the new estrogenic component of combined oral contraceptives 75
The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism 75
The impact of COVID-19 lockdown on admission to gynecological emergency departments: Results from a multicenter Italian study 67
Contemporary prescriptions pattern of different dose levonorgestrel-releasing intrauterine systems in an Italian service for family planning 64
Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study 49
The use of different doses levonorgestrel-releasing intrauterine system (LNG-IUS): real-world data from a multicenter Italian study 49
BRCA mutation carriers’ perception about benefits and risks associated with combined hormonal contraceptives use 42
Contraception and Cardiovascular Diseases 39
Drospirenone 4 mg in a 24 + 4 regimen in women with contraindications to oestrogen use for contraception: bleeding patterns according to previous menstrual characteristics 27
Postpartum contraception: A matter of guidelines 14
Totale 1.117
Categoria #
all - tutte 8.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020117 0 4 20 6 8 18 12 10 11 15 6 7
2020/2021207 10 17 3 26 27 8 1 15 3 20 5 72
2021/2022264 38 12 12 5 10 19 4 12 34 40 48 30
2022/2023308 39 45 20 13 35 50 5 25 39 5 13 19
2023/2024212 4 13 6 30 40 17 29 16 8 11 18 20
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 1.117